✦ LIBER ✦

162. Phase II clinical trial with hexamethylene bisacetamide (HMBA) in myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML)

✍ Scribed by Michaeli, J; Andreeff, M; Stone, R; Young, CL; Kufe, D; Rifkind, RA; Marks, Pa

Book ID: 122443612
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 131 KB
Volume: 46
Category: Article
ISSN: 0753-3322
DOI: 10.1016/0753-3322(92)90247-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discordant expression of AC133 and AC141

Discordant expression of AC133 and AC141 in patients with myelodysplastic syndrome (MDS) and acute myelogeneous leukemia (AML)

✍ Green, C L; Loken, M; Buck, D; Deeg, H J 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB

Phase I trial of sodium salicylate in pa

Phase I trial of sodium salicylate in patients with myelodysplastic syndromes and acute myelogenous leukemia

✍ Virginia M. Klimek; Emily K. Dolezal; Larry Smith; Gerald Soff; Stephen D. Nimer 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Phase I dose escalation study of bortezo

Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)

✍ Attar, Eyal C.; Amrein, Philip C.; Fraser, James W.; Fathi, Amir T.; McAfee, Ste 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 390 KB

Results of a multicenter phase II trial

Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) using low-dose Ara-C and Imatinib

✍ Florian Heidel; Jorge Cortes; Frank G. Rücker; Walter Aulitzky; Laurie Letvak; T 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

A Phase I/II Trial of Combination of PKC

A Phase I/II Trial of Combination of PKC412 and 5-azacytidine (AZA) for the Treatment of Patients with Refractory or Relapsed (R/R) Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

✍ Nazha, Aziz; Kantarjian, Hagop; Borthakur, Gautam; Kadia, Tapan; Faderl, Stefan; 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 76 KB

Clofarabine in combination with a standa

Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)

✍ Willemze, R.; Suciu, S.; Muus, P.; Halkes, C. J. M.; Meloni, G.; Meert, L.; Karr 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 197 KB